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Background: Loss of brain volume in ﬁrst-episode psychosis can be detected using conventional magnetic
resonance imaging (MRI), but subtle changes – not leading to reduction in volume – that may contribute to
clinical and cognitive abnormalities, may go undetected. Magnetization transfer imaging (MTI), a technique
more sensitive to subtle neuropathological changes than conventional MRI, could yield important
information on the extent and nature of structural abnormalities.
Methods: Forty-eight patients (33 males) from a population-based sample with ﬁrst-episode psychosis (41
with schizophrenia and 7 with schizoaffective psychosis) and 47 healthy volunteers (27 males) were
studied. Differences in magnetization transfer ratio (MTR) and white and grey matter volumes between
groups were investigated.
Results: In patients, MTR was reduced in right entorhinal cortex, fusiform, dentate and superior frontal gyri
and in left superior frontal and inferior/rostral cingulate gyri. Grey matter volume was reduced in right
insula, frontal operculum and middle and superior temporal gyri and in left middle temporal gyrus. Grey
matter volume increases were seen in patients in the superior frontal gyrus. White matter volume loss was
found adjacent to grey matter loss. In patients MTR was lower in all areas of volumetric differences between
groups suggesting that both changes may be related. Similar ﬁndings were observed when patients with
schizoaffective psychosis were removed from the analysis. The correlations between clinical and MRI
parameters did not survive correction for multiple comparisons.
Conclusions:MTI frontal and temporal abnormalities suggesting neuroaxonal and myelin changes were more
extensive in our patients than those detected with conventional MRI. Our ﬁndings also suggest that there is
regional variation in the severity of structural brain abnormalities.© 2009 Elsevier Inc. Open access under CC BY license. Introduction
Brain imaging abnormalities are present in the ﬁrst episode of
schizophrenia (Borgwardt et al., 2008; Steen et al., 2006) and its
prodrome (Lappin et al., 2007; Pantelis et al., 2003; Borgwardt et al.,
2006). Predominantly frontal greymatter losses, but also extending to
temporal and limbic regions at psychosis onset, (Fornito et al., 2009;
Glahn et al., 2008; Lui et al., 2009; Sun et al., 2009) with further losses
later in the illness, have been reported, (Lieberman et al., 2001;
Mathalon et al., 2001; Rapoport et al., 1997; DeLisi et al., 1997)
although there is no evidence to suggest neurodegeneration and a
variety of environmental factors may account for these ﬁndings (Rais
et al., 2008). Magnetization transfer imaging (MTI), an MRI modality
capable of detecting structural changes in the absence of volumetric license. loss, may prove helpful in studying the subtle abnormalities present in
ﬁrst-episode psychosis and their natural history. MTI (Wolff and
Balaban, 1989) is based on the interaction between protons bound to
macromolecules (e.g. myelin and cell membranes) and protons in free
water. An off-resonance pre-pulse allows the magnetization of bound
protons to be saturated and through chemical exchange and cross-
relaxation, magnetization is transferred to the free pool of protons,
reducing the MR signal. The degree of signal loss is expressed as the
magnetization transfer ratio (MTR), a highly reproducible measure in
normal subjects (Barker et al., 1996). MTR depends on the density of
macromolecules, and pathological processes that damage the macro-
molecular structure result in MTR reductions, often in the absence of
demonstrable atrophy in neurological illness such as multiple
sclerosis (Audoin et al., 2006; Fernando et al., 2005) and epilepsy
(Flugel et al., 2006; Rugg-Gunn et al., 2003).
We have previously reported bilateral MTR reductions in the
medial prefrontal cortex, insula and adjacent white matter in patients
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2003). The studywe present here was conducted in a larger, unrelated
group of patients with ﬁrst-episode psychosis using an improved,
three-dimensional (3D)-MTI sequence with much thinner slices than
our previous studies, along with voxel-based morphometry (VBM)
using a matched 3D (volumetric) acquisition. We aimed (i) to see if
similar MTI abnormalities could be detected in a larger sample of
patients using optimized MTI methodology, and (ii) to elucidate the
link between MTR and volumetric changes, and to explore MRI/
clinical correlations.
Methods
The patients were recruited as part of a prospective, longitudinal
study of ﬁrst-episode psychosis in West London. Patients eligible for
the study were screened using the WHO Psychosis Screen (Jablensky
et al., 1992). Patients were initially included if aged between 16 and
50 years, presenting with a psychotic illness for the ﬁrst time and had
received no more than 12 weeks of antipsychotic medication. In
addition to the WHO Psychosis Screen (Jablensky et al., 1992),
clinical notes were reviewed to exclude a previous ﬁrst episode of
psychosis. Clinical ratings were performed within 12 weeks of com-
mencing antipsychotic medication. Diagnoses was ascertained using
a structured interview, the diagnostic module of the Diagnostic
Interview for Psychosis (DIP, Jablensky et al., 2000). Patients and
their community mental health teams were contacted 1 year later at
which time the diagnosis was reviewed by two psychiatrists (TREB
and EMJ). Not all patients that were eligible underwent MRI
scanning; about half of those approached did not participate with
scanning either because they refused or were unable to tolerate the
scanning procedure. Forty-eight patients (33 males, 15 females) were
included in the study. Forty-one had a ﬁnal DSMIV diagnosis of
schizophrenia and seven of schizoaffective disorder.
Forty-seven healthy subjects (27 males and 20 females) served as
control subjects and were recruited from the same catchment area as
patients by advertising in local colleges and hospitals. For the controls,
participants were excluded if they had a history of psychiatric illness
in themselves or their ﬁrst-degree relatives. For both groups, exclu-
sion criteria were previous head injury or other neurological illness or
endocrine disorder affecting brain function, such as epilepsy and
thyroid disease, and drug or alcohol dependence.
Symptom severity and range were assessed with the Scales for the
Assessment of Positive (Andreasen, 1984a,b) and Negative (Andrea-
sen, 1984a,b) Symptoms, the Young Mania Scale (Young et al., 1978)
and the Hamilton Rating Scale for Depression (Hamilton, 1960). Age
of onset and duration of untreated psychosis were established using
the Symptom Onset in Schizophrenia inventory (Perkins et al., 2000).
The Alcohol and Drug Use Scales (Drake et al., 1990) were used to
determine dependency. Handedness was assessed using the Annett
scale (Annett, 1970).
Permission for the study was obtained from Merton, Sutton and
Wandsworth, Riverside and Ealing research ethics committees. All
participants gave written informed consent and received an hono-
rarium for taking part in the study.
MRI data acquisition
MRI was performed with a GE Signa 1.5 T scanner (General
Electric, Milwaukee, WI, USA). A T1-weighted volumetric image was
obtained using a 3D inversion recovery prepared spoiled gradient-
recalled echo (SPGR) sequence in the axial plane. This sequence
obtained 156 contiguous axial slices (TE=5 ms, TR=14 ms,
matrix=256×128, ﬁeld of view (FOV)=31×16 cm2, slice
thickness=1.2 mm, NEX=1, excitation ﬂip angle 20°, bandwidth
15.63, inversion time 450 ms). In addition, a 3D MT-prepared SPGR
was performed (TE=5 ms, TR=22 ms, NEX=1, ﬂip angle=10°,bandwidth 15.63 kHz, with 350°, 6.4 ms, Hamming-apodized three-
lobe sinc pulse applied 2 kHz from water resonance for MT
saturation), with slice thickness, matrix size and FOV matched to
the inversion recovery prepared SPGR. The MT sequence generated
two volumes, one with and one without MT saturation.
Image processing
Image processing was performed on a Sun workstation (Sun
Microsystems, Santa Clara, CA, USA). Initially the two volumes from
the MT SPGR sequence were co-registered to each other with an
afﬁne transformation using FLIRT (Jenkinson et al., 2002), to com-
pensate for involuntary movement during acquisition. MTR maps
were then calculated on a pixel-by-pixel basis using the formula
MTR=([Mo−Ms]/Mo)×100 percent units (pu), where Ms and Mo
are mean signal intensities with and without the saturation pulse,
respectively.
Further processing was then performed using SPM2 (Wellcome
Department of Cognitive Neurology, London, UK) in MATLAB
(MathWorks, Natick, MA, USA) with an “optimized VBM” approach
(Good et al., 2001) and matched steps on the MTR maps:
Co-registration of MTR and T1-weighted images
Non-MT-weighted scans from the MT sequence were co-regis-
tered to the corresponding T1-weighted volume; only a rigid body
(6-degree-of-freedom) transformation was necessary for this stage,
as the scans both used high resolution 3D sequences with very
similar acquisition parameters and the aim was simply to correct for
intra-subject, inter-scan, head motion. The same transformation was
applied to the MTR maps. All images were thus in the space of the T1-
weighted volume (Studholme et al., 1997).
Segmentation of the T1-weighted images in native space
This was performed in native space using the SPM2 Bayesian
algorithm (Ashburner and Friston, 1997) to assign voxels as grey
matter, white matter, or cerebrospinal ﬂuid.
Normalization
Grey matter images were spatially normalized into MNI (Montreal
Neurological Institute) stereotactic space using the SPM2 a priori grey
matter image as a template. Normalization was ﬁrst obtained using a
12-parameter afﬁne transformation and was then optimized using 16
non-linear warps (Ashburner and Friston, 1997). The optimized
transformation parameters were then applied to the original T1-
weighted images and MTR maps.
Segmentation
Normalized T1-weighted images were segmented to produce grey
matter, white matter, and cerebrospinal ﬂuid segments. This iterative
procedure was used because normalization is ideally performed on
segmented images, while segmentation is better performed in stereo-
tactic space (Good et al., 2001).
Modulation
Possible changes in regional shape to ﬁt the template during
warping affects the quantiﬁcation of grey and white matter density,
resulting in an artiﬁcially altered tissue density. The true amount of
tissue volume per voxel is retrieved by dividing the image intensity by
the regional volumetric deformation factor—a procedure referred to
as Jacobian modulation (Ashburner and Friston, 2001).
Smoothing
MTR maps and segmented images of grey and white matter
were smoothed with a 12 mm FWHM Gaussian kernel to address
possible residual registration errors and inter-individual variability
and to ensure the normality requirements of parametric statistics
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analysis, (Jones et al., 2005; Honea et al., 2005) we selected a
12 mm kernel that is often used in schizophrenia studies (McClure
et al., 2006a,b; Spencer et al., 2007; Yamada et al., 2007) and is less
likely than smaller kernels to detect group differences of uncertain
signiﬁcance.
Volumetric and MTR group comparisons
These were made using SPM2 in the framework of the general
linear model, including the total grey or white matter volume as a
covariate for the volumetric data, and total brain volume for the
whole-brain MTR analysis. Differences in these measures in patients
relative to controls were investigated using t tests and corrected for
multiple comparisons using a family-wise error correction at Pb0.05.
These t tests produced statistical parametric maps depicting regions
that differed signiﬁcantly between groups.
Post-hoc clinical/MRI correlations
Means for MTR and for grey and white matter volumes were
calculated for each cluster where differences between groups were
present, using the “volume-of-interest” option in SPM2 and correla-
tions with positive, negative and disorganization symptoms explored
using Pearson's correlations.
Post-hoc MTR group comparisons in areas of volume change
To explore the relationship between MTR and volume changes,
the mean MTR values of patients and controls were compared for
the brain regions where grey or white matter volumes differed
signiﬁcantly. An image mask for these regions was constructed and
overlaid on each subject's smoothed whole-brain MTR images.
Mean MTR values for the areas covered by this mask were
obtained for each subject, and group comparisons made using an
independent-samples t test.
Results
The mean age for patients was 26.2 years (range 16–50) and for
controls, 24.8 years (range 16–37). Four patients and six controls
were left-handed. No subject fulﬁlled criteria for alcohol or drug
dependency.
All patients received antipsychotic medication (23 olanzapine, 16
risperidone, 4 aripiprazole, 3 amisulpride, 1 quetiapine, 1 haloperidol)
and 7 were also prescribed antidepressants. The average duration of
treatment before scanning was 77 (9–186) days. For those taking
olanzapine, the average dose was 14.25 mg and average duration ofTable 1
Number of voxels and Talairach coordinates of signiﬁcant clusters (Pb0.05, corrected for fam
Change in patients Number of voxels
in clustera
Max Talairach
coordinates (x y z)
MTR decrease 1417 28 −14 −24
439 −4 48 −3
775 13 27 52
187 −8 32 52
Grey matter decrease 710 −64 −48 −3
1566 56 −25 −4
577 45 −16 18
281 64 −32 22
Grey matter increase 65 18 13 52
3274 −14 3 61
1728 18 −5 67
White matter decrease 2045 38 −26 3
74 −29 −27 11
MTR, magnetization transfer ratio.
a b10 voxelss not reported.treatment before scanning was 83 days. For those taking risperidone,
the average dose was 3.5 mg with an average duration of treatment
prior to scanning of 79 days.
Those patients that were scanned did not signiﬁcantly differ from
those that refused or were unable to be scanned in terms of total SAPS
scores (scanned mean=30.8, unscanned mean=30.4; t=0.123,
df=119, P=0.903) and total SANS scores (scanned mean=16.3,
unscanned mean=18.8; t=0.426, df=119, P=0.671). There were
also no signiﬁcant differences in terms of duration of untreated illness
(scanned mean=33 months, unscanned mean=27 months;
t=1.049, df=119, P=0.296).
There were no signiﬁcant differences between patients and
controls in age (t=−0.043, df=93, P=0.348), gender (χ2=1.304,
df=1, P=0.254) or handedness (χ2=0.495, df=1, P=0.482).
Current IQ data were not available for all subjects and more subjects
participated with premorbid IQ estimation (Wechsler Test of Adult
Reading, Pearson, TX, USA) than current IQ testing. For those subjects
that had premorbid IQ estimates available, patients (n=30, mean
predicted IQ=95, SD 14.2) had signiﬁcantly lower estimates than
controls (n=36, mean predicted IQ=103, SD 10.1); (t=2.674,
df=64, P=0.01).
MTR group differences
In patients, MTR reduction in the right hemisphere was observed
in the fusiform gyrus, entorhinal cortex, dentate gyrus, and superior
frontal gyrus. Areas of MTR reduction in the left hemisphere were
seen in the superior frontal gyrus and inferior/rostral cingulate gyrus.
There were no MTR increases in patients relative to controls.
MRI volumetric group differences
Grey matter
In the patient group, grey matter loss was seen in the middle
temporal gyrus, insula, frontal operculum and superior temporal
gyrus on the right and in the left middle temporal gyrus.
A bilateral increase in grey matter volume involving the superior
frontal gyrus and a small region of the right superior temporal gyrus
was present in patients compared with controls.
White matter
White matter loss occurred in patients in areas bordering the
right insular gyrus and the middle and superior temporal gyri and
in the left temporal subgyral and insular regions. There were no
areas of increased white matter volume in patients.ily-wise error) in SPMmaps showing differences between patients and control subjects.
Area
Right. Grey matter: dentate gyrus, fusiform, uncus, entorhinal cortex.
White matter: periventricular around temporal horn
Left. Grey matter: inferior and superior rostral gyrus, cingulate, gyrus rectus
and underlying white matter
Right. Grey matter: superior frontal gyrus and underlying white matter
Left. Grey matter: superior frontal gyrus
Left. Middle temporal gyrus
Right. Middle temporal gyrus
Right. Grey matter: frontal operculum/insular gyrus
Right. Grey matter: superior temporal gyrus/planum temporale/insula
Right. Superior temporal gyrus
Left. Superior frontal gyrus
Right. Superior frontal gyrus
Right. Posterior internal capsule. White matter adjacent to insular gyrus,
putamen and superior temporal gyrus
Left. Adjacent to insular gyrus
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plots for 90% Conﬁdence Intervals for the most signiﬁcant cluster in
each group difference are shown in Fig. 2.Analysis excluding schizoaffective patients
When the 7 patients with schizoaffective psychosis were
excluded from the analysis (n=41) very similar ﬁndings in terms
cluster size and distribution for volume loss, grey matter volume
increases in patients and MTR differences were revealed. This dis-
tribution is shown in Fig. 3.Fig. 1. Statistical parametric maps depicting the different regions where MTR and brain v
multiple comparisons), overlaid on a standard template using SPM2. Blue denotes MTR re
group). Green denotes grey matter volume increases in the patient group.Post-hoc clinical/MTR and volumetric correlations
Severity of total positive symptoms score (SAPS) and the severity
of the ﬂattening of affect subscale score from the SANS correlated
with MTR reduction in the right medial temporal region (coordinates
28 −14 −24) (Pearson's correlation coefﬁcients −0.285, P=0.05,
and −0.313, P=0.03, respectively). Flattening of affect correlated
with MTR reduction in the left fronto/cingulate region (Pearson's
correlation coefﬁcient −0.296, P=0.041), and longer duration of
untreated illness with MTR reduction in the right superior frontal
gyrus (coordinates 13, 27, 52) (Pearson's correlation coefﬁcient
−0.353, P=0.014). These correlations were no longer signiﬁcantolume differed signiﬁcantly between groups (Pb0.05, family-wise error corrected for
duction; red, grey matter volume loss; and yellow, white matter reductions (patient
Fig. 2. 90% Conﬁdence Intervals in the most signiﬁcant clusters for white and grey matter decreases in patients, grey matter increases in patients and MTR reductions in patients.
Control (n=47) data are plotted ﬁrst (1=Controls, 2=Patients) and coordinates are shown in the glass brain (arrow) and vertical axis.
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There were no signiﬁcant correlations between clinical ratings and
grey or white matter volume loss. There were also no signiﬁcant
Pearson's correlations for risperidone or olanzapine dose×duration
in areas of grey and white matter loss and MTR reductions in
patients, as well as grey matter increase in patients.
Post-hoc group comparisons of MTR in areas of volume change
In areas where the grey matter volume was decreased in patients,
meanMTR values were 35.47 pu (SD=1.15) for patients and 36.11 pu
(SD=0.91) for controls (t=−2.97, df=93, P=0.004). In areas
where white matter volume was decreased in patients, mean MTR
values were 42.06 pu (SD=1.10) for patients and 42.67 pu
(SD=0.97) for controls (t=−2.89, df=93, P=0.005). In areas
where the grey matter volume was increased in patients, mean MTR
values were 32.49 pu (SD=1.45) for patients and 33.37 pu
(SD=1.49) for controls (t=−2.93, df=93, P=0.004).
Discussion
Using two complementary modalities of structural MRI, we
have obtained results suggesting that frontal and temporal abnor-
malities are present in patients with ﬁrst-episode psychosis. The
severity of these abnormalities was greater in temporal regions,
and more so in the right hemisphere. Our results also suggest that
MTI provides additional, complementary information to that of
volumetric MRI regarding the extent of pathological changes early
in the course of the illness.
Loss of grey matter in fronto-temporal regions has been reported
in other studies of patients with ﬁrst-episode psychosis, (Choi et al.,
2005; Chua et al., 2007; Pantelis et al., 2003) although the ﬁne
localization of volumetric changes varies between studies, presu-
mably because of the heterogeneity of patient populations and
methodologies. Loss of fronto-temporal white matter has been
reported less frequently in ﬁrst-episode psychosis, (Ho et al., 2003;
Whitford et al., 2007) although reduction in the numbers of
oligodendrocytes, (Uranova et al., 2004) abnormal expression of
myelin-related genes, (Hakak et al., 2001) and changes in theintegrity of white matter tracts shown using diffusion-tensor MRI
(Price et al., 2007, 2008) suggest that white matter abnormalities
are also present early in the disease. Right-sided volumetric losses
in temporal and frontal regions have also been reported in other
studies using voxel-based morphometry, although less frequently
than left-sided ones (Honea et al., 2005).
In post-mortem brains, imaging correlations suggest that white
matter MTR depends on myelin and, to a lesser extent, on axonal
density, (Schmierer et al., 2007) and MTR reduction is strongly
associated with tissue damage. The pathological abnormalities
leading to MTR changes in grey matter are less well documented,
but with less abundant myelin, decrease in the number and/or size
of neurones, loss of dendritic arborisation, and changes in proteins
and phospholipids in cell membranes are likely to account for
reductions in MTR. It is also unclear how tissue changes detected by
MTR relate to any reductions in brain volume also seen. In a follow-
up study of patients with multiple sclerosis, Khaleeli et al. (2007)
reported only a moderate correlation between MTR decreases and
grey and white matter atrophy over one year, although atrophy did
not fully explain the MTR changes and the authors concluded that,
although MTR measures need to be interpreted in the context of
atrophy, MTR was also an independent marker of pathology. Thus,
MTR appears to detect subtle neuropathological changes, not all of
which result in detectable tissue volume loss. In our patients, MTR
changes were more extensive than grey and white matter
volumetric losses, particularly in frontal regions. This could indicate
more severe abnormalities in some brain regions (i.e. the temporal
as compared with the frontal lobes) and/or subtle differences in the
nature of neuropathological changes. In our previous 3-year ﬁrst-
episode follow-up study of a different small group of patients we
failed to detect MTR changes over time (Price et al., 2006) and a
larger follow-up study would be needed to elucidate the relation-
ship between changes in MTR and volumetric loss.
The lack of overlap between areas of volume loss and MTR
reduction in the temporal lobe deserves comment. Differences in
volumetric and MTR data analysis are unlikely to explain this dis-
sociation, although grey and white matter data were modulated and
therefore weighted for the effects of local atrophy, whereas MTR
data were not. Because of the larger number of voxels, more
Fig. 3. Statistical parametric maps of schizophrenia only patients compared to controls. The maps depict the different regions where MTR and brain volume differed signiﬁcantly
between groups (Pb0.05, family-wise error corrected for multiple comparisons), overlaid on a standard template using SPM2. Blue denotes MTR reduction; red, grey matter volume
loss; and yellow, white matter reductions (patient group). Green denotes grey matter volume increases in the patient group.
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MTR than to the volumetric data as MTR analysis was performed
over the whole brain, while grey matter volume was by deﬁnition
assessed only over the grey matter; however lowering the
acceptable level of signiﬁcance did not change our ﬁndings, and
further removes the possibility that the MTR results are artifactual.
On the other hand, mean MTR was lower in the patient group in all
areas of volume loss in post-hoc comparisons. This supports the
ﬁndings of Khaleeli et al. (2007) suggesting that while there is a
link between MTR reduction and loss of brain volume, MTR may be
an independent marker of pathology. The possibility that MTR ismore sensitive that volumetric loss to the current or cumulative
effects of antipsychotic medication remains a possibility, however,
the fact that a dissociation between these two parameters has also
been described in other studies of patients not exposed to
neuroleptics (Khaleeli et al., 2007) makes this unlikely.
The grey matter volume increase in the superior frontal gyrus,
an area not generally associated with abnormalities in schizophre-
nia, was unexpected. Since MTR reduction was seen in this area in
the patient group, it is possible that concomitant changes in SPGR
signal intensity at the grey/white matter boundary may have
resulted in tissue misclassiﬁcation. An alternative explanation is that
191G. Price et al. / NeuroImage 49 (2010) 185–192exposure to atypical antipsychotics (Lieberman et al., 2005) could
have caused grey matter increases. Our ﬁndings of a focal increase
in grey matter volume in the superior frontal gyri have support
from other studies that have found grey matter volume increases in
this region (McClure et al., 2006a,b) and other cortical frontal
regions (Molina et al., 2005; Stip et al., 2009), although these and
other studies (Garver et al., 2005) also show medication-related
cortical thickening that tends to be more diffuse than the very focal
change described here.
Correlations between symptom severity and volumetric loss in
prefrontal and temporal regions have been reported in ﬁrst-episode
psychosis, (Kim et al., 2003) and others (Roth et al., 2004) have found
predominantly right-sided fronto-temporal volumetric loss in those
with high negative symptom scores. The reduction of MTR in fronto-
temporal regions with increased symptom severity in our patients
echoes previous reports, even if correction is modest. The loss of these
correlations after multiple comparison adjustment is probably
associated with medication-related symptomatic improvement. On
the other hand our ﬁndings add support to those of Ho et al. (2003)
who failed to ﬁnd an association between duration of untreated
psychosis and imaging abnormalities.
This is to date the largest MTI and volumetric study of ﬁrst-
episode psychosis. In our previous study, (Bagary et al., 2003)
involving a different group of 30 ﬁrst-episode patients and 30
controls, MTR reductions were present in the medial prefrontal
cortex, insula, and fasciculus uncinatus without loss of brain
volume. In the study reported here, the more sophisticated image
acquisition and larger sample size are likely to account for the
more extensive areas of MTR reduction and volumetric loss, as
otherwise the characteristics of the subjects in the two studies
were similar. In our previous MTI study of patients with chronic
schizophrenia, (Foong et al., 2001) we reported more diffuse
cortical abnormalities, prominent in the inferior and middle frontal,
inferior and middle temporal, and superior occipital gyri, with
extension into the white matter of the uncinate fasciculus. The
ﬁndings of our two previous studies are not strictly comparable
with those reported here, as there were differences in sample sizes,
patient populations, MTI sequences and image analysis methods
(SPM2 versus SPM99). However, all three studies revealed frontal
and/or temporal MTR abnormalities with little or no loss of brain
volume, although the ﬁne localization of abnormalities differed
between studies. Outside our group, others have reported small
MTR reductions in patients with chronic schizophrenia in periven-
tricular regions and temporal lobes (Antosik-Biernacka et al., 2006)
or more signiﬁcant in fronto-occipital and fronto-thalamic connec-
tions (Kubicki et al., 2005).
The use of a 3D MTI sequence, with high spatial resolution,
matched to that of the volumetric scan, should improve the accuracy
in the localization of abnormal areas. Nevertheless, the smoothing
process, needed to render the residuals of the model ﬁtted to the data
more normally distributed, is likely to introduce some degree of
partial volume effect. The size of the smoothing ﬁlter is known to
affect the results (Jones et al., 2005) and we cannot exclude the
possibility of ﬁnding a slightly different pattern of abnormalities with
a smaller smoothing kernel.
The exclusion of the small number of patients with schizoaffective
illness in our sample did not alter themain ﬁndings. The small number
of schizoaffective patients did not allow us to examine their imaging
in detail but there is evidence that volumetric loss in the neocortex
(Nakamura et al., 2007) and prefrontal MTR reductions are also
present in affective psychosis (Bruno et al., 2004).
The results reported here extend those of our previous studies
and go some way towards elucidating the link between MTR and
volumetric loss. They also provide evidence that MTI can detect
structural brain changes not visible with conventional MRI and
support the view that the combined use of these two MRImodalities may prove useful in elucidating structural brain abnor-
malities in psychosis and in determining their natural history.
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